Advertisement

Topics

AMORCHEM L.P. Company Profile

18:23 EST 19th January 2019 | BioPortfolio

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating primarily from Quebec-based universities and research centres. Launched in 2011, the AmorChem fund model combines access to financial resources with a virtual incubator structure that enables the rapid development and commercialization of its technologies. The first fund (41.2M$) has built a portfolio of 24 technologies and successfully transacted two pharma exits as well as spun-out five companies. The attractiveness of this seed fund model and the role it plays in the life science ecosystem were highlighted in September 2017 with the launch of the AmorChem II fund of 44.2M$.


News Articles [9 Associated News Articles listed on BioPortfolio]

MyX spins off from AmorChem with $450k in seed funding

Venture capital fund AmorChem has spun off MyX Therapeutics Inc. and provided the firm with $450k in seed funding.

Amorchem Selected for Investment by the Venture Capital Catalyst Initiative

November 6th, 2018, AmorChem is proud to be amongst the successful applicants of the Venture Capital Catalyst Initiative (“VCCI”) Stream II, announced yesterday in Montreal by...

AmorChem, KNOCK OUT Event, 5th round

Back by popular demand, AmorChem is hosting its fifth KNOCK OUT Event during the 1st edition of the EFFERVERSCENCE conference, April 24th, 2019 in Montreal. Researchers sel...

AmorChem Spins out Its Muco-Adhesive Nanoparticle Delivery Platform into MyX Therapeutics, with 450,000$ Seed Investment.

AmorChem announces today the creation of MyX Therapeutics Inc, its sixth spin-off company focusing on MyX-001, a biodegradable muco-adhesive nanoparticle delivery platform, capabl...

AmorChem Invests in Groundbreaking RNA Technology

AmorChem II is proud to announce the closing of its first financing of a university project. The venture capital fund has reached an agreement with Univalor, Dr Éric Lécuyer of ...

Inversago brings in $7mm via Series A

Inversago Pharma Inc. raised $7mm through its Series A financing co-led by Genesys Capital and AmorChem, which were joined by JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Tarnagulla Ventures, and a...

SemaThera Board Names Garth Cumberlidge as President & CEO

SemaThera Inc., announces today that its board of directors has appointed Garth Cumberlidge as President and Chief Executive Officer. Dr. Cumberlidge was also elected to the board...

Mperia Therapeutics Appoints Paul Chipperton as President and CEO

November 9, 2018, Mperia’s Board of Directors announces today the appointment of Mr Paul Chipperton, as the new President and CEO, effective immediately. He will lead CD36 devel...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

AmorChem

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...

AMORCHEM L.P.

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...

More Information about "AMORCHEM L.P." on BioPortfolio

We have published hundreds of AMORCHEM L.P. news stories on BioPortfolio along with dozens of AMORCHEM L.P. Clinical Trials and PubMed Articles about AMORCHEM L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AMORCHEM L.P. Companies in our database. You can also find out about relevant AMORCHEM L.P. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...


Corporate Database Quicklinks



Searches Linking to this Company Record